close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Vetter Pharma International GmbH

News headline image
Pharmaceutical Service Provider Vetter Pharma to Build New Manufacturing Site in Germany
From Vetter Pharma International GmbH
Via Business Wire
News headline image
Vetter Achieves Top Sustainability Rating and Expands Climate Goal Commitments
From Vetter Pharma International GmbH
Via Business Wire
News headline image
Vetter Reaches Key Launch Milestones for the V-OVS® next Tamper-Evident Syringe Closure System
From Vetter Pharma International GmbH
Via Business Wire
News headline image
Vetter Marks the Start of New Clinical Site Construction with Groundbreaking Ceremony
From Vetter Pharma International GmbH
Via Business Wire
News headline image
Vetter Once Again Named Best Managed Company
From Vetter Pharma International GmbH
Via Business Wire
News headline image
Vetter Prioritizes Continuity and Action in Its Sustainability Efforts
From Vetter Pharma International GmbH
Via Business Wire
News headline image
Vetter Boosts Pharmaceutical Storage Capacity With Major Warehouse Expansion
From Vetter Pharma International GmbH
Via Business Wire
News headline image
Vetter introduces the next evolution of the V-OVS® syringe closure system
From Vetter Pharma International GmbH
Via Business Wire
News headline image
Vetter Strengthens Senior Management Team for Further Sustainable Growth
From Vetter Pharma International GmbH
Via Business Wire
News headline image
Vetter Announces Plans to Expand Its Capacity in the U.S. and Germany
From Vetter Pharma International GmbH
Via Business Wire
News headline image
Vetter wins Best Managed Companies Award 2024
From Vetter Pharma International GmbH
Via Business Wire
News headline image
Vetter Earns Prestigious Honors Across All Core Categories in the 13th Annual CDMO Leadership Awards
From Vetter Pharma International GmbH
Via Business Wire
News headline image
Vetter Contributes to Commercial Launches of Eight Customer Products in 2023
From Vetter Pharma International GmbH
Via Business Wire
News headline image
Vetter Becomes a Member of the German Association of Research-Based Pharmaceutical Companies (vfa)
From Vetter Pharma International GmbH
Via Business Wire
News headline image
A Leading Global CDMO Continues to Drive Its Sustainability Strategy Forward: Vetter Joins Science Based Targets Initiative (SBTi)
From Vetter Pharma International GmbH
Via Business Wire
News headline image
Vetter’s European Clinical Site Receives Permanent Manufacturer’s Authorization
From Vetter Pharma International GmbH
Via Business Wire
News headline image
Vetter looks ahead to further expansions to meet supply chain demand
From Vetter Pharma International GmbH
Via Business Wire
News headline image
Vetter Again Demonstrates Industry Leadership in Sustainability Initiatives
From Vetter Pharma International GmbH
Via Business Wire
News headline image
Vetter: Service Provider Further Expands Offerings for Clinical Development and Manufacturing
From Vetter Pharma International GmbH
Via Business Wire
News headline image
Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market
From Vetter Pharma International GmbH
Via Business Wire
News headline image
New Fully Automated Vetter Warehouse Expands Storage and Boosts Logistical Infrastructure
From Vetter Pharma International GmbH
Via Business Wire
News headline image
Vetter’s Newest Clinical Manufacturing Site Successfully Completed Its First Customer Fills
From Vetter Pharma International GmbH
Via Business Wire
News headline image
Vetter’s New Clinical Manufacturing Site Now Officially Authorized
From Vetter Pharma International GmbH
Via Business Wire
News headline image
Vetter and Rentschler Biopharma Further Strengthen their Strategic Alliance
From Vetter Pharma International GmbH
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today